• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用高场 MRI 检测阿尔茨海默病转基因模型中与淀粉样蛋白-β 相关的皮质和皮质下信号变化。

Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.

机构信息

Department of Psychiatry, University of Rostock, Rostock, Germany.

出版信息

J Alzheimers Dis. 2011;23(2):221-37. doi: 10.3233/JAD-2010-101035.

DOI:10.3233/JAD-2010-101035
PMID:20966552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3030673/
Abstract

In vivo imaging of amyloid-β (Aβ) load as a biomarker of Alzheimer's disease (AD) would be of considerable clinical relevance for the early diagnosis and monitoring of treatment effects. Here, we investigated automated quantification of in vivo T2 relaxation time as a surrogate measure of plaque load in the brains of ten AβPP/PS1 transgenic mice (age 20 weeks) using in vivo MRI acquisitions on a 7T Bruker ClinScan magnet. AβPP/PS1 mice present with rapid-onset cerebral β-amyloidosis, and were compared with eight age-matched, wild-type control mice (C57Bl/6J) that do not develop Aβ-deposition in brain. Data were analyzed with a novel automated voxel-based analysis that allowed mapping the entire brain for significant signal changes. In AβPP/PS1 mice, we found a significant decrease in T2 relaxation times in the deeper neocortical layers, caudate-putamen, thalamus, hippocampus, and cerebellum compared to wildtype controls. These changes were in line with the histological distribution of cerebral Aβ plaques and activated microglia. Grey matter density did not differ between wild-type mice and AβPP/PS1 mice, consistent with a lack of neuronal loss in histological investigations. High-field MRI with automated mapping of T2 time changes may be a useful tool for the detection of plaque load in living transgenic animals, which may become relevant for the evaluation of amyloid lowering intervention effects in future studies.

摘要

体内成像淀粉样蛋白-β(Aβ)负荷作为阿尔茨海默病(AD)的生物标志物,对于早期诊断和治疗效果监测具有重要的临床意义。在这里,我们使用 Bruker ClinScan 磁体上的 7T 活体 MRI 采集,研究了自动量化活体 T2 弛豫时间作为斑块负荷的替代指标在 10 只 AβPP/PS1 转基因小鼠(20 周龄)脑中的应用。AβPP/PS1 小鼠表现出快速发作的脑β淀粉样蛋白病,并与 8 只年龄匹配的野生型对照小鼠(C57Bl/6J)进行比较,后者在脑中不会发生 Aβ沉积。使用一种新的自动体素分析方法对数据进行了分析,该方法允许对整个大脑进行显著信号变化的映射。在 AβPP/PS1 小鼠中,与野生型对照组相比,我们发现深层皮质层、尾状核、丘脑、海马体和小脑的 T2 弛豫时间明显降低。这些变化与大脑 Aβ斑块和激活的小胶质细胞的组织分布一致。与组织学研究中神经元缺失一致,野生型小鼠和 AβPP/PS1 小鼠之间的灰质密度没有差异。高场 MRI 结合 T2 时间变化的自动映射可能是检测活体转基因动物斑块负荷的有用工具,这可能在未来的研究中对评估淀粉样蛋白降低干预效果具有重要意义。

相似文献

1
Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.利用高场 MRI 检测阿尔茨海默病转基因模型中与淀粉样蛋白-β 相关的皮质和皮质下信号变化。
J Alzheimers Dis. 2011;23(2):221-37. doi: 10.3233/JAD-2010-101035.
2
Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.脑淀粉样变性和脑源性神经营养因子缺乏对AβPP/PS1小鼠的脑容量在体内和体外均有相反的影响。
J Alzheimers Dis. 2015;46(4):929-46. doi: 10.3233/JAD-150059.
3
The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.局灶性脑损伤对阿尔茨海默病APP/PS1小鼠模型中β-淀粉样蛋白斑块沉积、炎症和突触的影响。
Exp Neurol. 2015 May;267:219-29. doi: 10.1016/j.expneurol.2015.02.034. Epub 2015 Mar 4.
4
Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.羟氯喹可减少神经突斑块中的锌积累,并抑制 APP/PS1 转基因小鼠大脑中的淀粉样蛋白生成途径。
J Alzheimers Dis. 2012;29(3):549-59. doi: 10.3233/JAD-2011-111874.
5
Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.光学和 SPION 增强磁共振成像显示,NF-κB 的反式二苯乙烯抑制剂可同时降低 AβPP/PS-1 转基因小鼠大脑中的阿尔茨海默病斑块形成和小胶质细胞激活。
J Alzheimers Dis. 2014;40(1):191-212. doi: 10.3233/JAD-131031.
6
Brain regions differences in amyloid-β and gene expression in early APP/PS1 mice and identification ofNpas4 as a key molecule in Alzheimer's disease.早期 APP/PS1 小鼠脑区淀粉样蛋白-β和基因表达的差异及 Npas4 作为阿尔茨海默病关键分子的鉴定。
Biomol Biomed. 2024 Oct 17;24(6):1816-1826. doi: 10.17305/bb.2024.10820.
7
Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.阿尔茨海默病样淀粉样变性模型中 Aβ 沉积形态和二级蛋白质组不可溶性的多样性。
Acta Neuropathol Commun. 2020 Apr 6;8(1):43. doi: 10.1186/s40478-020-00911-y.
8
Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.一种新型肽基磁共振造影剂在野生型和阿尔茨海默病转基因小鼠中的药代动力学及淀粉样斑块靶向能力
J Pharmacol Exp Ther. 2007 Aug;322(2):541-9. doi: 10.1124/jpet.107.119883. Epub 2007 May 15.
9
Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.在阿尔茨海默病小鼠模型的大脑中,小胶质细胞因摄取β淀粉样蛋白而导致细胞死亡,从而促进斑块生长。
Glia. 2016 Dec;64(12):2274-2290. doi: 10.1002/glia.23074. Epub 2016 Sep 23.
10
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.胶原阿尔茨海默氏淀粉样斑块成分影响淀粉样-β斑块的致密化。
Acta Neuropathol Commun. 2020 Dec 7;8(1):212. doi: 10.1186/s40478-020-01075-5.

引用本文的文献

1
Correcting for imaging gradients-related bias of T relaxation times at high-resolution MRI.校正高分辨率 MRI 中与成像梯度相关的 T 弛豫时间偏差。
Magn Reson Med. 2022 Oct;88(4):1806-1817. doi: 10.1002/mrm.29319. Epub 2022 Jun 6.
2
Neuroimaging of Mouse Models of Alzheimer's Disease.阿尔茨海默病小鼠模型的神经影像学
Biomedicines. 2022 Jan 28;10(2):305. doi: 10.3390/biomedicines10020305.
3
T2 heterogeneity: a novel marker of microstructural integrity associated with cognitive decline in people with mild cognitive impairment.

本文引用的文献

1
GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.符合药品生产质量管理规范(GMP)的[(18)F]AV-45(氟代硼吡咯 F 18)自动化合成,用于人脑β-淀粉样蛋白斑块成像。
Appl Radiat Isot. 2010 Dec;68(12):2293-7. doi: 10.1016/j.apradiso.2010.07.001. Epub 2010 Jul 7.
2
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.阿尔茨海默病的生物标志物:学术、工业和监管视角。
Nat Rev Drug Discov. 2010 Jul;9(7):560-74. doi: 10.1038/nrd3115.
3
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.
T2 异质性:与轻度认知障碍患者认知能力下降相关的微观结构完整性的新标志物。
Alzheimers Res Ther. 2020 Sep 10;12(1):105. doi: 10.1186/s13195-020-00672-9.
4
[Detection algorithm of amyloid β-protein deposition in magnetic resonance image based on pixel feature learning method].基于像素特征学习方法的磁共振图像中β淀粉样蛋白沉积检测算法
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2017 Jun 1;34(3):431-438. doi: 10.7507/1001-5515.201603061.
5
In vivo microscopic voxel-based morphometry with a brain template to characterize strain-specific structures in the mouse brain.基于体素的脑模板的活体微观形态计量学,用于描述小鼠大脑中的应变特异性结构。
Sci Rep. 2017 Mar 7;7(1):85. doi: 10.1038/s41598-017-00148-1.
6
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.老年APPPS1-21小鼠体内葡萄糖利用的分子神经成像及其与纤维状淀粉样β蛋白负荷的关联
Alzheimers Res Ther. 2015 Dec 15;7(1):76. doi: 10.1186/s13195-015-0158-6.
7
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.攻克阿尔茨海默病的未来之路:针对所有阶段和目标人群的预防试验开发生物标志物和神经成像方法。
J Prev Alzheimers Dis. 2014 Dec;1(3):181-202. doi: 10.14283/jpad.2014.32.
8
A review of β-amyloid neuroimaging in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白神经影像学综述。
Front Neurosci. 2014 Oct 31;8:327. doi: 10.3389/fnins.2014.00327. eCollection 2014.
9
Animal Models of Alzheimer's Disease: Utilization of Transgenic Alzheimer's Disease Models in Studies of Amyloid Beta Clearance.阿尔茨海默病的动物模型:转基因阿尔茨海默病模型在淀粉样β蛋白清除研究中的应用
Curr Transl Geriatr Exp Gerontol Rep. 2012 Mar;1(1):11-20. doi: 10.1007/s13670-011-0004-z. Epub 2012 Jan 19.
基于 MRI 的阿尔茨海默病内侧颞叶容积测量的多中心变异性。
Psychiatry Res. 2010 Jun 30;182(3):244-50. doi: 10.1016/j.pscychresns.2010.03.003. Epub 2010 May 20.
4
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.阿尔茨海默病病理级联的动态生物标志物假设模型。
Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6.
5
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.一名具有阿尔茨海默病临床、认知及脑脊液标志物的患者中匹兹堡化合物B检测未发现脑淀粉样β蛋白:病例报告
Arch Neurol. 2009 Dec;66(12):1557-62. doi: 10.1001/archneurol.2009.279.
6
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.基于 MRI 的脑萎缩模式自动检测在阿尔茨海默病预测中的应用。
Neuroimage. 2010 Mar;50(1):162-74. doi: 10.1016/j.neuroimage.2009.11.046. Epub 2009 Dec 2.
7
Functionally relevant domains of the prion protein identified in vivo.体内鉴定的朊病毒蛋白功能相关结构域。
PLoS One. 2009 Sep 7;4(9):e6707. doi: 10.1371/journal.pone.0006707.
8
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease.匹兹堡化合物 B 高亲和力结合缺陷在阿尔茨海默病病例中的表现。
Acta Neuropathol. 2010 Feb;119(2):221-33. doi: 10.1007/s00401-009-0583-3. Epub 2009 Aug 19.
9
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.匹兹堡化合物B衍生物18F-氟代甲磺酸在健康志愿者和疑似阿尔茨海默病患者中的1期研究。
J Nucl Med. 2009 Aug;50(8):1251-9. doi: 10.2967/jnumed.109.063305. Epub 2009 Jul 17.
10
Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?阿尔茨海默病与血脑屏障功能——抗β-淀粉样蛋白疗法为何未能阻止痴呆症进展?
Neurosci Biobehav Rev. 2009 Jul;33(7):1099-108. doi: 10.1016/j.neubiorev.2009.05.006. Epub 2009 May 27.